Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Johnson & Johnson's OneTouch Proves Not All Recalls Are Alike
Motley Fool
Tuesday, March 26, 2013 - 10:50am
tags:
recalls, LifeScan, JNJ, blood glucose monitoring
Trius targets key approvals after antibiotic matches Zyvox (again) in Phase III
Fierce Biotech
Tuesday, March 26, 2013 - 10:41am
tags:
Trius, antiobiotics, Zyvox, tedizolid
Will Dendreon Continue to Plummet?
Wall St. Cheat Sheet
Tuesday, March 26, 2013 - 10:38am
tags:
Dendreon, Provenge
Halozyme Rallies On Success In Europe, US Next Target
Seeking Alpha
Tuesday, March 26, 2013 - 10:38am
tags:
Halozyme, Europe, Baxter International, HyQvia
Acceleron Receives Two FDA Orphan Designations for ACE-536
Yahoo
Tuesday, March 26, 2013 - 10:34am
tags:
FDA, orphan drugs, ACE-536, Acceleron, beta-thalassemia, myelodysplastic syndromes
Ziopharm cancer drug fails in late-stage trial; shares plunge
Reuters
Tuesday, March 26, 2013 - 10:31am
tags:
Ziopharm, palifosfamide, soft tissue sarcomas
Pipeline Setback at BioLineRx
Yahoo/Zacks
Tuesday, March 26, 2013 - 10:30am
tags:
BioLineRx, BL-1020, schizophrenia
Savient Pharmaceuticals: Is Anything Left?
Seeking Alpha
Tuesday, March 26, 2013 - 10:29am
tags:
Krystexxa, Savient, gout
Idenix Pharma shares sink after regulators determine competitor filed drug patent first
Yahoo/AP
Tuesday, March 26, 2013 - 10:28am
tags:
Gilead Pharmasset, patents, Idenix
Shares of Acadia Pharma jump on confidence a top drug candidate will be approved
Yahoo/AP
Tuesday, March 26, 2013 - 10:27am
tags:
Acadia, pimavanserin, Parkinson's Disease Psychosis
Biogen And The Progress In Multiple Sclerosis Treatment
Seeking Alpha
Tuesday, March 26, 2013 - 10:26am
tags:
MS, multiple sclerosis, Biogen Idec, Tecfidera, BG-12
New Legislation Proposes to Limit Approved Uses for Controlled Release Oxycodone-Hydrochloride for Relief of “Severe-Only” Pain
FDA Law Blog
Tuesday, March 26, 2013 - 10:23am
tags:
oxycontin
Feuerstein: Amarin's Sloooow Vascepa Launch
TheStreet.com
Tuesday, March 26, 2013 - 10:20am
tags:
Amarin, Vascepa, drug launches
Phytopharm gives up after Parkinson's drug failure
Reuters
Tuesday, March 26, 2013 - 10:19am
tags:
Parkinson's Disease, Phytopharm, Cogane
Shire to Buy Eye-Drug Maker SARcode for $160 Million
Bloomberg
Tuesday, March 26, 2013 - 10:18am
tags:
SARcode, M&A, Shire
Pfizer's drug to treat tuberculosis in short supply
Reuters
Tuesday, March 26, 2013 - 10:17am
tags:
Pfizer, tuberculosis, drug shortages, Rifampin
Why Amarin Is Struggling So Much
Seeking Alpha
Tuesday, March 26, 2013 - 10:16am
tags:
Amarin, GSK
Otsuka to Pay Lundbeck $825 Million for Alzheimer’s Drug
Bloomberg
Tuesday, March 26, 2013 - 10:15am
tags:
Otsuka, Alzheimer's disease, Lu AE58054
Aubagio EU Backing Comes With Generic Worries
Seeking Alpha
Tuesday, March 26, 2013 - 9:33am
tags:
Aubagio, Europe, generics, Sanofi, MS, multiple sclerosis
Eli Lilly Submits New Type 2 Diabetes Drug for FDA Review
Motley Fool
Tuesday, March 26, 2013 - 9:20am
tags:
diabetes, FDA, Eli Lilly, Boehringer Ingelheim, empagliflozin

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.